104
Participants
Start Date
December 31, 2004
Study Completion Date
December 31, 2006
rituximab
Albany Medical Center, Albany
Geisinger Medical Center, Danville
University Of Pennsylvania Medical Center, Philadelphia
University of Maryland Hospital MS Center, Baltimore
MS Center Of Atlanta, Atlanta
Medical College of Georgia, Augusta
Neurology Associates, P.A., Maitland
Neurological Services Of Orlando, Orlando
Multiple Sclerosis Center of Brevard, Melbourne
MS Center of Vero Beach, Vero Beach
Neurological Associates, Pompano Beach
Kentucky Neuroscience Research, Louisville
The Ohio State University, Columbus
The Cleveland Clinic Foundation, Cleveland
Neurology and Neuroscience Assoc.,INC, Akron
Michigan Institute For Neurological Disorders, Farmington Hills
St. Luke's Medical Center/Center for Neurological Disorders, Milwaukee
Meritcare Neuroscience Clinic, Fargo
Deaconess Billings Clinical Research Division, Billings
University Of Kansas Medical Center, Kansas City
Neurology Specialists of Dallas, PA, Dallas
Maxine Mesinger MS Clinic/ Baylor College of Medicine, Houston
Neurology Clinic of San Antonio, San Antonio
Phoenix Neurological Associates, Phoenix
Loma Linda University, Loma Linda
Neurological Research Institute Of East Bay, Walnut Creek
Sutter Gould Medical Foundation, Modesto
University Of California At Davis, Sacramento
Virginia Mason Medical Center, Seattle
Neurology and Neurosurgery Associates of Tacoma, Inc., P.S., Tacoma
Holy Family MS Center, Spokane
Lead Sponsor
Genentech, Inc.
INDUSTRY